The global narcotics scanner market was valued at $6.89 billion in 2020, and is projected to reach $12.59 billion by 2030, registering a CAGR of 6.6%. Based on end use, the airport segment contributed to the highest share in 2020, accounting for more than two-fifths of the total share, and is projected to maintain its leadership status during the forecast period. Moreover, this segment is expected to manifest the fastest CAGR of 7.4% from 2021 to 2030. The report also analyzes the segments including railways, seaports, and others..

According to a new study published by Knowledge Sourcing Intelligence, the ultrasonic fingerprint sensor market is projected to grow at a CAGR of 24.53% between 2025 and 2030 to reach US$2,096.074 billion in 2030. Ultrasonic fingerprint sensor is a biometric authentication that uses high-frequency sound waves to create a 3D image of a fingerprint.

Industry Analysis 2025: The US biotech sector is poised for significant transformation in 2025 under the second Trump administration, with regulatory shifts and market dynamics creating both opportunities and challenges for industry players. Regulatory Reset The Federal Trade Commission’s approach to merger control is expected to undergo substantial changes, marking a departure from the Biden administration’s stringent oversight. This shift is likely to catalyze M&A activity, particularly in the $5-15 billion transaction range. The appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services introduces uncertainty, particularly regarding vaccine development and pharmaceutical approvals. Market Growth Trajectory Despite political uncertainties, the global biotech market demonstrates robust growth potential, projected to expand from $483 billion in 2024 to $546 billion in 2025, representing a 13% increase. This growth is driven by technological advancements and sustained R&D investments across the… 

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that Health Canada has authorized Vabysmo® (faricimab injection) for use in a 6.0 mg single-use pre-filled syringe (PFS) for use in the treatment of wet, or neovascular, age-related macular degeneration (AMD), diabetic macular edema (DME) and macular edema secondary to retinal vein occlusion (RVO).1 These leading causes of vision loss affect around 70 million people worldwide and can have a serious impact on patients, their families, and caregivers. Supply for Vabysmo PFS will become available to Canadian ophthalmologists and their patients in the coming months. Roche Canada is committed to continuing to work with the provincial and territorial jurisdictions to make Vabysmo PFS available as soon as possible through public and private drug plans for the patients who need it. Vabysmo is the first and only bispecific antibody approved for… 

Personen mit der Hautkrankheit Psoriasis haben oft unsichtbare Entzündungen im Dünndarm mit einer erhöhten Neigung zu einem „undichten Darm“, so neue Forschungsergebnisse der Universität Uppsala. Diese Veränderungen im Darm könnten erklären, warum Psoriasispatienten häufig Magen-Darm-Probleme haben und anfälliger für die Entwicklung von Morbus Crohn sind. Die Studie wurde in der Zeitschrift Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease veröffentlicht. Schuppenflechte ist eine erbliche, chronische Hauterkrankung, die auch zu Entzündungen der Gelenke führen kann. In Schweden leben fast 300.000 Menschen mit einer Form der Krankheit. Chronisch entzündliche Darmerkrankungen (IBD), insbesondere Morbus Crohn, treten bei Patienten mit Psoriasis häufiger auf als in der übrigen Bevölkerung. „Frühere Untersuchungen haben auch gezeigt, dass Menschen mit Psoriasis häufiger Magen-Darm-Probleme haben als die Allgemeinbevölkerung. Wir wussten jedoch nicht viel darüber, warum dies der Fall ist. Mit unserer Studie können wir nun zeigen, dass…